User contributions
Jump to navigation
Jump to search
- 14:50, 14 May 2021 diff hist +599 m Prostate cancer TITAN study final analysis reference
- 19:59, 13 May 2021 diff hist +459 Breast cancer, HER2-positive Tolaney 7 year update reference
- 20:16, 12 May 2021 diff hist +402 Urothelial carcinoma reference for RTOG 0524 Tag: visualeditor
- 20:06, 12 May 2021 diff hist +589 m Urothelial carcinoma paclitaxel RT Pham 2014
- 04:38, 8 May 2021 diff hist +58 m Cold agglutinin disease →Sutimlimab monotherapy: formating Tag: visualeditor
- 04:28, 8 May 2021 diff hist +215 Cold agglutinin disease Sutimlimab regimen NEJM 2021
- 04:15, 8 May 2021 diff hist -198 m Cold agglutinin disease removed sutimlimab from investigational agents
- 04:12, 8 May 2021 diff hist +449 Cold agglutinin disease Cold agglutinin disease new regimen with sutimlimab summary table
- 21:10, 30 April 2021 diff hist -201 m Antiemesis minor edit Tag: visualeditor
- 20:52, 30 April 2021 diff hist +22 m Antiemesis atezo update and drug index Tag: visualeditor
- 20:40, 30 April 2021 diff hist +24 m Antiemesis ado-trastuzumab and altretamine antiemetic updates Tag: visualeditor
- 20:27, 30 April 2021 diff hist +14 m Antiemesis atezolizumab emetic potential update Tag: visualeditor
- 20:38, 15 October 2020 diff hist +222 m Antiemesis →Emetic risk of chemotherapy, immunotherapy, TKIs and other agents Tag: visualeditor
- 20:36, 15 October 2020 diff hist +110 m Antiemesis →Emetic risk of chemotherapy, immunotherapy, TKIs and other agents: Olaparib Tag: visualeditor
- 23:39, 20 July 2020 diff hist -6 m Hematology Oncology Fellowship Programs Directory →Hematology oncology fellowship programs: JMC Tag: visualeditor
- 23:36, 20 July 2020 diff hist +16 m Hematology Oncology Fellowship Programs Directory →Hematology oncology fellowship programs: JMC Tag: visualeditor
- 22:08, 29 October 2019 diff hist +253 N Talk:Small cell lung cancer Caspian study
- 20:15, 6 September 2019 diff hist +63 m Antiemesis Pixantrone and Pembrolizumab emetic MASCC risk Tag: visualeditor
- 20:12, 6 September 2019 diff hist +61 m Antiemesis added new agents to main table and emetic risk by MASCC Tag: visualeditor
- 20:01, 6 September 2019 diff hist +32 m Antiemesis added trabectedine to table with emetic potential by MASCC Tag: visualeditor